Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Nature medicine [Nat Med] NLMUID: 9502015"" wg kryterium: JN


Tytuł :
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
Autorzy :
Schmidt T; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Klemis V; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Schub D; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Mihm J; Department of Internal Medicine IV, Saarland University, Homburg, Germany.
Hielscher F; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Marx S; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Abu-Omar A; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Ziegler L; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Guckelmus C; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Urschel R; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany.
Schneitler S; Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Becker SL; Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Gärtner BC; Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.
Sester U; Department of Internal Medicine IV, Saarland University, Homburg, Germany.
Sester M; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 26. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Autorzy :
Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Hossain NM; Division of Hematology/Oncology, Loyola University Medical Center, Chicago, IL, USA.
Oak J; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Baird JH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Shiraz P; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Craig J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Iglesias M; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Younes S; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Natkunam Y; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Ozawa MG; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Yang E; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Tamaresis J; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Chinnasamy H; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Reynolds W; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Lynn R; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Lyell Immunopharma, San Francisco, CA, USA.
Rotiroti MC; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Gkitsas N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Johnston L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Lowsky R; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Majzner RG; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Meyer E; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Negrin RS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Rezvani AR; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Shizuru J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Weng WK; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.
Mullins C; Adaptive Biotechnologies, Seattle, WA, USA.
Jacob A; Adaptive Biotechnologies, Seattle, WA, USA.
Kirsch I; Adaptive Biotechnologies, Seattle, WA, USA.
Bazzano M; IsoPlexis, Brantford, CT, USA.
Zhou J; IsoPlexis, Brantford, CT, USA.
Mackay S; IsoPlexis, Brantford, CT, USA.
Bornheimer SJ; BD Biosciences, San Jose, CA, USA.
Schultz L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Ramakrishna S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Davis KL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Shah NN; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Qin H; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Fry T; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.; Department of Pediatrics-Hematology/Oncology, University of Colorado Anschutz and Children's Hospital Colorado, Denver, CO, USA.
Feldman S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. .; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA. .
Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. .; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 26. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Accelerating the translational medicine cycle: the Academia Europaea pilot.
Autorzy :
Hegyi P; Institute for Translational Medicine, Szentágothai Research Centre, Medical School, University of Pécs, Pécs, Hungary. .; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. .; Centre for Translational Medicine, First Department of Medicine, University of Szeged, Szeged, Hungary. .
Erőss B; Institute for Translational Medicine, Szentágothai Research Centre, Medical School, University of Pécs, Pécs, Hungary. .; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. .
Izbéki F; Szent György University Teaching Hospital of Fejér County, Székesfehérvár, Hungary. .
Párniczky A; Institute for Translational Medicine, Szentágothai Research Centre, Medical School, University of Pécs, Pécs, Hungary. .; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. .; Heim Pál National Pediatric Institute, Budapest, Hungary. .
Szentesi A; Institute for Translational Medicine, Szentágothai Research Centre, Medical School, University of Pécs, Pécs, Hungary. .; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. .; Centre for Translational Medicine, First Department of Medicine, University of Szeged, Szeged, Hungary. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 26. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
A 'mix and match' approach to SARS-CoV-2 vaccination.
Autorzy :
Deming ME; The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Lyke KE; The Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 26. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A new treatment combination for liver cancer.
Autorzy :
O'Leary K
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 22. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Wiadomości
Periodyk
Tytuł :
Publisher Correction: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
Autorzy :
Jin Y; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.; Department of Nephrology, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Ratnam K; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Chuang PY; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Fan Y; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Zhong Y; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Dai Y; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Mazloom AR; Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA.; Systems Biology Center New York (SBCNY), New York, New York, USA.
Chen EY; Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA.; Systems Biology Center New York (SBCNY), New York, New York, USA.
D'Agati V; Department of Pathology, Columbia University, New York, New York, USA.
Xiong H; Immunobiology Center, Mount Sinai School of Medicine, New York, New York, USA.
Ross MJ; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA.
Chen N; Department of Nephrology, Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Ma'ayan A; Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA. .; Systems Biology Center New York (SBCNY), New York, New York, USA. .
He JC; Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA. .; Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, USA. .; James J. Peters Veteran Administration Medical Center, New York, New York, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 20. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Published Erratum
Tytuł :
Population-wide diversity and stability of serum antibody epitope repertoires against human microbiota.
Autorzy :
Vogl T; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Klompus S; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Leviatan S; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Kalka IN; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Weinberger A; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel. .; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. .
Wijmenga C; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Fu J; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Zhernakova A; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Weersma RK; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Segal E; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel. .; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 19. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Understanding COVID-19 vaccine hesitancy.
Autorzy :
Machingaidze S; European and Developing Countries Clinical Trials Partnership, Africa Office, Cape Town, South Africa. .; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. .
Wiysonge CS; School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 16. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.
Autorzy :
Solís Arce JS; WZB Berlin Social Science Center, Berlin, Germany.
Warren SS; Innovations for Poverty Action (IPA), New York, NY, USA.
Meriggi NF; International Growth Centre (IGC), Freetown, Sierra Leone.
Scacco A; WZB Berlin Social Science Center, Berlin, Germany.
McMurry N; WZB Berlin Social Science Center, Berlin, Germany.
Voors M; Wageningen University & Research, Wageningen, the Netherlands.
Syunyaev G; WZB Berlin Social Science Center, Berlin, Germany.; International Center for the Study of Institutions and Development (ICSID), HSE University, Moscow, Russia.; Columbia University, New York, NY, USA.
Malik AA; Yale Institute for Global Health, New Haven, CT, USA.
Aboutajdine S; International Growth Centre (IGC), Freetown, Sierra Leone.
Adeojo O; Busara Center for Behavioral Economics, Lagos, Nigeria.; Department of Sociology, University of Lagos, Lagos, Nigeria.
Anigo D; Busara Nigeria, Lagos, Nigeria.; Agricultural and Rural Development Secretariat, Federal Capital Territory Administration, Abuja, Nigeria.
Armand A; Nova School of Business and Economics, Lisbon, Portugal.; The Institute for Fiscal Studies, London, UK.
Asad S; Lahore University of Management Sciences, Lahore, Pakistan.
Atyera M; Innovations for Poverty Action (IPA) Uganda, Kampala, Uganda.
Augsburg B; The Institute for Fiscal Studies, London, UK.
Awasthi M; Morsel Research & Development, Lucknow, India.
Ayesiga GE; Innovations for Poverty Action (IPA) Uganda, Kampala, Uganda.
Bancalari A; The Institute for Fiscal Studies, London, UK.; University of St Andrews, St Andrews, UK.; Redes Peru, Lima, Peru.
Björkman Nyqvist M; Stockholm School of Economics and Misum, Stockholm, Sweden.
Borisova E; International Center for the Study of Institutions and Development (ICSID), HSE University, Moscow, Russia.; Ghent University, Department of Economics, Ghent, Belgium.
Bosancianu CM; WZB Berlin Social Science Center, Berlin, Germany.
Cabra García MR; Innovations for Poverty Action (IPA) Colombia, Bogotá, Colombia.
Cheema A; Lahore University of Management Sciences, Lahore, Pakistan.; Institute of Development and Economic Alternatives, Lahore, Pakistan.
Collins E; Innovations for Poverty Action (IPA), New York, NY, USA.
Cuccaro F; Innovations for Poverty Action (IPA) Sierra Leone, Freetown, Sierra Leone.
Farooqi AZ; Institute of Development and Economic Alternatives, Lahore, Pakistan.
Fatima T; Morsel Research & Development, Lucknow, India.
Fracchia M; Nova School of Business and Economics, Lisbon, Portugal.; NOVAFRICA, Lisbon, Portugal.
Galindo Soria ML; Innovations for Poverty Action (IPA) Colombia, Bogotá, Colombia.
Guariso A; Trinity College Dublin, Dublin, Ireland.
Hasanain A; Lahore University of Management Sciences, Lahore, Pakistan.
Jaramillo S; Innovations for Poverty Action (IPA) Colombia, Bogotá, Colombia.
Kallon S; Wageningen University & Research, Wageningen, the Netherlands.; Institute of Public Administration and Management, University of Sierra Leone, Freetown, Sierra Leone.
Kamwesigye A; Innovations for Poverty Action (IPA) Uganda, Kampala, Uganda.
Kharel A; Centre for the Study of Labour and Mobility (CESLAM), Kathmandu, Nepal.
Kreps S; Cornell University, Ithaca, NY, USA.
Levine M; Wageningen University & Research, Wageningen, the Netherlands.
Littman R; University of Illinois Chicago, Chicago, IL, USA.
Malik M; Institute of Development and Economic Alternatives, Lahore, Pakistan.
Manirabaruta G; Innovations for Poverty Action (IPA) Rwanda, Kigali, Rwanda.
Mfura JLH; Innovations for Poverty Action (IPA) Rwanda, Kigali, Rwanda.
Momoh F; Innovations for Poverty Action (IPA) Sierra Leone, Freetown, Sierra Leone.
Mucauque A; Associação NOVAFRICA para o Desenvolvimento Empresarial e Económico de Moçambique, Maputo, Mozambique.
Mussa I; Associação NOVAFRICA para o Desenvolvimento Empresarial e Económico de Moçambique, Maputo, Mozambique.
Nsabimana JA; Innovations for Poverty Action (IPA) Rwanda, Kigali, Rwanda.
Obara I; Busara Center for Behavioral Economics, Lagos, Nigeria.
Otálora MJ; Innovations for Poverty Action (IPA) Colombia, Bogotá, Colombia.
Ouédraogo BW; Innovations for Poverty Action (IPA) Burkina Faso, Ouagadougou, Burkina Faso.
Pare TB; Innovations for Poverty Action (IPA) Burkina Faso, Ouagadougou, Burkina Faso.
Platas MR; NYU Abu Dhabi, Abu Dhabi, United Arab Emirates.
Polanco L; Innovations for Poverty Action (IPA) Colombia, Bogotá, Colombia.
Qureshi JA; University of Illinois Chicago, Chicago, IL, USA.
Raheem M; Centre for Economic Research in Pakistan (CERP), Lahore, Pakistan.
Ramakrishna V; Yale Research Initiative on Innovation and Scale (Y-RISE), New Haven, CT, USA.
Rendrá I; Associação NOVAFRICA para o Desenvolvimento Empresarial e Económico de Moçambique, Maputo, Mozambique.
Shah T; Centre for Economic Research in Pakistan (CERP), Lahore, Pakistan.
Shaked SE; Innovations for Poverty Action (IPA) Uganda, Kampala, Uganda.
Shapiro JN; Princeton University, Princeton, NJ, USA.
Svensson J; Institute for International Economic Studies (IIES), Stockholm University, Stockholm, Sweden.
Tariq A; Institute of Development and Economic Alternatives, Lahore, Pakistan.
Tchibozo AM; Innovations for Poverty Action (IPA) Burkina Faso, Ouagadougou, Burkina Faso.
Tiwana HA; Institute of Development and Economic Alternatives, Lahore, Pakistan.
Trivedi B; Morsel Research & Development, Lucknow, India.
Vernot C; Yale Research Initiative on Innovation and Scale (Y-RISE), New Haven, CT, USA.
Vicente PC; Nova School of Business and Economics, Lisbon, Portugal.; NOVAFRICA, Lisbon, Portugal.
Weissinger LB; Tufts University, Medford, MA, USA.
Zafar B; Centre for Economic Research in Pakistan (CERP), Lahore, Pakistan.; University of Michigan, Ann Arbor, MI, USA.
Zhang B; Cornell University, Ithaca, NY, USA.
Karlan D; Innovations for Poverty Action (IPA), New York, NY, USA.; Kellogg School of Management at Northwestern University, Evanston, IL, USA.
Callen M; London School of Economics and Political Science, London, UK.
Teachout M; International Growth Centre (IGC), Freetown, Sierra Leone.
Humphreys M; WZB Berlin Social Science Center, Berlin, Germany.; Columbia University, New York, NY, USA.
Mobarak AM; Yale University, New Haven, CT, USA. .
Omer SB; Yale Institute for Global Health, New Haven, CT, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 16. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
Autorzy :
Barros-Martins J; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Hammerschmidt SI; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Cossmann A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Odak I; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Stankov MV; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Morillas Ramos G; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Dopfer-Jablonka A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany.
Heidemann A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
Ritter C; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Friedrichsen M; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Schultze-Florey C; Institute of Immunology, Hannover Medical School, Hannover, Germany.; Department of Hematology, Hemostasis, Oncology and Stem-Cell Transplantation, Hannover Medical School, Hannover, Germany.
Ravens I; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Willenzon S; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Bubke A; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Ristenpart J; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Janssen A; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Ssebyatika G; Institute of Biochemistry, University of Lübeck, Lübeck, Germany.
Bernhardt G; Institute of Immunology, Hannover Medical School, Hannover, Germany.
Münch J; Ulm University Medical Center, Institute of Molecular Virology, Ulm, Germany.
Hoffmann M; Infection Biology Unit, German Primate Center, Göttingen, Germany.; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
Pöhlmann S; Infection Biology Unit, German Primate Center, Göttingen, Germany.; Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.
Krey T; Institute of Biochemistry, University of Lübeck, Lübeck, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig and Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
Bošnjak B; Institute of Immunology, Hannover Medical School, Hannover, Germany. .
Förster R; Institute of Immunology, Hannover Medical School, Hannover, Germany. .; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany. .; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany. .
Behrens GMN; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany. .; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany. .; CiiM, Centre for Individualised Infection Medicine, Hannover, Germany. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 14. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Giving voice to Black women in science and medicine.
Autorzy :
Ighodaro ET; Department of Neurology, Mayo Clinic, Rochester, MN, USA. .
Littlejohn EL; Office of Global Health and Health Disparities, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Akhetuamhen AI; Department of Emergency Medicine, McGaw Medical Center of Northwestern University, Chicago, IL, USA.
Benson R; Office of Global Health and Health Disparities, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 12. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
A French cohort for assessing COVID-19 vaccine responses in specific populations.
Autorzy :
Loubet P; Department of Infectious and Tropical Diseases, INSERM U1047, Centre Hospitalier Universitaire (CHU) Nîmes, University of Montpellier, Nîmes, France. .; INSERM, French Clinical Research Infrastructure Network, Réseau Innovative Clinical Research in Vaccinology, Paris, France. .
Wittkop L; Institut de Santé Publique d'Epidémiologie et de Développement, INSERM, Bordeaux Population Health Research Center, UMR 1219, Centre d'Investigation Clinique-Epidémiologie Clinique 1401, University of Bordeaux, Bordeaux, France.; Service d'Information Médicale, CHU de Bordeaux, Pôle de Santé Publique, Bordeaux, France.
Tartour E; Service Immunologie Biologique, Paris-Centre de Recherche Cardiovasculaire, INSERM U970, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Européen Georges Pompidou, Université de Paris, Paris, France.
Parfait B; Fédération des Centre de Ressources Biologiques-Plateforme de Ressources Biologiques APHP, Centre-Université de Paris, Centre de Ressources Biologique Cochin, Hôpital Cochin, Paris, France.
Barrou B; Service de Transplantation Rénale, Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France.
Blay JY; Centre Leon Berard UNICANCER et Université Lyon I, Lyon, France.
Hourmant M; Service de Néphrologie-Immunologie clinique, CHU Nantes, Nantes, France.
Lachâtre M; INSERM, French Clinical Research Infrastructure Network, Réseau Innovative Clinical Research in Vaccinology, Paris, France.; Centre d'Investigation Clinique (CIC) Cochin Pasteur, APHP, Hôpital Cochin, Paris, France.
Laplaud DA; Centre de Recherche en Transplantation et Immunologie-INSERM U1064, Service de Neurologie, CIC 1413, Université de Nantes, CHU Nantes, Nantes, France.
Laville M; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Association Française d'Etudes et de Recherche de l'Obésité, French Clinical Research Infrastructure Network-French Obesity Research Centre of Excellence Network, Nantes, France.
Laviolle B; University of Rennes, CHU Rennes, INSERM, CIC 1414, Rennes, France.
Lelievre JD; Vaccine Research Institute, INSERM and APHP, Hôpital H. Mondor, Créteil, France.
Morel J; Rheumatology Department, CHU and University of Montpellier, Montpellier, France.
Nguyen S; APHP-Sorbonne Université, INSERM U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses-Paris, Paris, France.
Spano JP; APHP-Sorbonne Université, Institut Pierre Louis d'Epidemiologie et de Santé Publique INSERM 1136, Paris, France.
Terrier B; Service de Médecine Interne, Hôpital Cochin, APHP, Paris, France.
Thiebaut A; Département d'Hématologie, CHU Grenoble Alpes, Grenoble, France.
Viallard JF; Université de Bordeaux, Hôpital Haut-Lévêque, Bordeaux, France.
Vrtovsnik F; Service de Néphrologie, Hôpital Bichat-Claude Bernard, APHP, Departement Hospitalo-Universitaire Fire, Université de Paris, Paris, France.
de Lamballerie X; Unité des Virus Émergents, Aix-Marseille Université, Institut de Recherche pour le Développement 190, INSERM 1207, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.
Launay O; INSERM, French Clinical Research Infrastructure Network, Réseau Innovative Clinical Research in Vaccinology, Paris, France.; INSERM, CIC Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Université de Paris, Sorbonne Paris Cité, Paris, France.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 12. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology.
Autorzy :
Wang L; Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA.
Sievert D; Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA.
Clark AE; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Lee S; Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA.
Federman H; Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA.; Center for Immunity and Inflammation, New Jersey Medical School, Rutgers University, Newark, NJ, USA.
Gastfriend BD; Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Shusta EV; Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.; Department of Neurological Surgery, University of Wisconsin-Madison, Madison, WI, USA.
Palecek SP; Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Carlin AF; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA. .
Gleeson JG; Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. .; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA, USA. .; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 09. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
Autorzy :
Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
Yassine HM; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Benslimane FM; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Al Khatib HA; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Tang P; Department of Pathology, Sidra Medicine, Doha, Qatar.
Hasan MR; Department of Pathology, Sidra Medicine, Doha, Qatar.
Malek JA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
Coyle P; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Hamad Medical Corporation, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.
Ayoub HH; Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.
Al Kanaani Z; Hamad Medical Corporation, Doha, Qatar.
Al Kuwari E; Hamad Medical Corporation, Doha, Qatar.
Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
Latif AN; Hamad Medical Corporation, Doha, Qatar.
Shaik RM; Hamad Medical Corporation, Doha, Qatar.
Abdul Rahim HF; College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Nasrallah GK; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
Al Kuwari MG; Primary Health Care Corporation, Doha, Qatar.
Al Romaihi HE; Ministry of Public Health, Doha, Qatar.
Al-Thani MH; Ministry of Public Health, Doha, Qatar.
Al Khal A; Hamad Medical Corporation, Doha, Qatar.
Butt AA; Hamad Medical Corporation, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Bertollini R; Ministry of Public Health, Doha, Qatar.
Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar. .; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar. .; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 09. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection.
Autorzy :
Dedrick RM; Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Freeman KG; Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Nguyen JA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bahadirli-Talbott A; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Smith BE; Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Wu AE; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ong AS; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lin CT; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ruppel LC; Investigational Pharmacy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Parrish NM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hatfull GF; Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA. .
Cohen KA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 08. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Tuberculosis Drug Accelerator at year 10: what have we learned?
Autorzy :
Aldridge BB; Tufts University, Boston, MA, USA.
Barros-Aguirre D; GlaxoSmithKline, Tres Cantos, Spain.
Barry CE 3rd; National Institutes of Health, Bethesda, MD, USA.
Bates RH; GlaxoSmithKline, Tres Cantos, Spain.
Berthel SJ; Panorama Global, Seattle, WA, USA.
Boshoff HI; National Institutes of Health, Bethesda, MD, USA.
Chibale K; University of Cape Town, Cape Town, South Africa.
Chu XJ; Global Health Drug Discovery Institute, Beijing, China.
Cooper CB; Global Alliance for TB Drug Development, New York, NY, USA.
Dartois V; Hackensack Meridian Health Center for Discovery & Innovation, Nutley, NJ, USA.
Duncan K; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Fotouhi N; Global Alliance for TB Drug Development, New York, NY, USA.
Gusovsky F; Eisai, Andover, MA, USA.
Hipskind PA; Lgenia, Fortville, IN, USA.
Kempf DJ; AbbVie, North Chicago, IL, USA.
Lelièvre J; GlaxoSmithKline, Tres Cantos, Spain.
Lenaerts AJ; Colorado State University, Fort Collins, CO, USA.
McNamara CW; Calibr, a division of the Scripps Research Institute, La Jolla, CA, USA.
Mizrahi V; University of Cape Town, Cape Town, South Africa.
Nathan C; Weill Cornell Medicine, New York, NY, USA. .
Olsen DB; Merck & Co., West Point, PA, USA.
Parish T; Seattle Children's Research Institute, Seattle, WA, USA.
Petrassi HM; Calibr, a division of the Scripps Research Institute, La Jolla, CA, USA.
Pym A; Janssen-Cilag, Buckinghamshire, UK.
Rhee KY; Weill Cornell Medicine, New York, NY, USA.
Robertson GT; Colorado State University, Fort Collins, CO, USA.
Rock JM; The Rockefeller University, New York, NY, USA.
Rubin EJ; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Russell B; Bill & Melinda Gates Medical Research Institute, Boston, MA, USA.
Russell DG; Cornell University, Ithaca, NY, USA.
Sacchettini JC; Texas A&M University, College Station, TX, USA.
Schnappinger D; Weill Cornell Medicine, New York, NY, USA.
Schrimpf M; AbbVie, North Chicago, IL, USA.
Upton AM; Evotec, Lyon, France.
Warner P; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Wyatt PG; Drug Discovery Unit, University of Dundee, Dundee, Scotland.
Yuan Y; Global Health Drug Discovery Institute, Beijing, China.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Jul 05. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies